Background: Several studies have suggested a possible role of human papillomavirus and
INTRODUCTION
Several studies have suggested a possible role of human papillomavirus (HPV) and EpsteinBarr virus (EBV) in the pathogenesis of oral carcinoma and presence of HPV and EBV in oral premalignant lesions (OPL) (1-3) and oral squamous benign lesions (3, (4) (5) (6) (7) . Single way for detection have limitations(8). HPV induced carcinogenesis is associated with low pRb protein levels which leads to subsequent p16 upregulation (1) . p16 protein normally acts to block cell cycle progression at the G1 to S transition; therefore, inactivation of the p16 gene enables unregulated cell growth (6) . OPLs is most reliable predictors of malignant development (5) . Histopathologic evaluation of dysplasia is subjective and there is differences inter-and intra-observer (9) (10) (11) . This study aimed to investigate the correlation between squamous dysplasia localized tongue (TSD) and expression of p16 and Ki67 immunohistochemically and HPV genotypes with Real-time PCR.
MATERIALS AND METHODS
Twenty three tongue biopsy specimens diagnosed as pre-neoplastic (n:17) and suspicious lesions for dysplasia and HPV infection (n:6) with coilocytic changes microscopically, have Immunohistochemical studies were performed using Bond™ Polymer Refine Detection method (Leica Biosystems Newcastle Ltd, UK) with diaminobenzidine as the chromogen and hematoxylin as the nuclear counterstain. All immunohistochemical process was performed using the Leica BOND-MAX™ automated system. Included antibodies were anti-p16 (clone R19-D; DB Biotech, Kosice, Slovak Republic; 1:100 dilution), anti-Ki67 (clone SP6; Biocare medical, CA, USA; 1:100 dilution) and anti-EBV (clones CS1, CS2, CS3 and CS4, Leica, Microsystems, UK; 1:100 dilution). All antibodies were diluted with Lab Vision Antibody Diluent (TA-125-AD). EBV and p16 staining were scored as strong, weak, or negative on the basis of nuclear and/or cytoplasmic staining. Weak cytoplasmic staining or reactivity in cells less than 5% was interpreted as negative. Diffuse (more than 80% or focal 5-80%) strong staining was scored as positive (13) . Ki67 staining was evaluated and scored according to the limited localization of basal layer (score:0) or extending to the upper layer (score:1).
All cases were investigated for the presence of HPV DNA by CISH method and analyzed the presence of HPV DNA, HPV III family 16 for HPV genotypes 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58 and 66. Real-time PCR for HPV performed by using the "HPV sign® Q24 complete" kit allows HPV virus detection and genotyping using "Rotor-Gene" and "PyroMark Q24" instrument system (Qiagen, Germany) for paraffin embedded tissues.
The "HPV sign® Q24 complete" kit allows to identify the HPV genotypes present in the sample using Identify PyroMark SW 1.0 or the equivalent IdentiFire TM software (Biotage AB, Sweden), which analyse and align the determined sequence with the library supplied in the kit. After amplification of DNA extracted from the biopsy on Rotor-Gene, detection and genotyping are respectively performed through melt curve analysis and Pyrosequencing. Immunoexpression analysis of Ki67 did not reveal statistically significant differences between the expression of markers and histopathological parameters, except Ki67 whose increased expression was associated with the decrease in high degree dysplasia (Spearman correlation test; r = 0.700, p=0.000).
One case with high grade dysplasia was positive ( Figure 1 ) for HPV by CISH and another case with low grade dyspalasia was positive for HPV by Real-time PCR. Both two positive cases were not successfully typed, probably due to insufficient quantity. The case with high grade dysplasia positive for HPV by CISH was also positive for p16. However, the case with low grade dysplasia and HPV positive with PCR was negative for p16.
There was no correlation between the nature of the lesion and presence of ulceration, inflammation, intraepithelial inflammatory infiltration, achantosis, parakeratosis, an increase of vascularity. There was a positive moderate correlation between the nature of the lesion and the presence of apoptosis which was not statistically significant, while p value was near to significant value (Spearman correlation test; r = 0.407, p=0.054).
DISCUSSION
Most common risk factor for development of oropharyngeal cancers are tobacco and alcohol.
HPV in oral and oropharyngeal carcinoma was first proposed by Syrjanen et al. in 1983(12) .
HPV has been found to be both in an episomal form and in an integral form. It has also been suggested that HPV may be latent for a long time in the episomal format in the oral mucosa, hence being responsible for initiation and development of a tumoral growth. This tumoral growth may occur as a result of a multicarcinogenic interaction together with some other carcinogens and co-carcinogens (13, 14) . Our study showed 2 of 16, that is, 12,5% HPV positivity with CISH in TSD, which is low but in accordance with the literature (1, 4, 6, 15, 18) . In the case of high dysplasia with Basak et al 7 HPV, positive immunohistochemical expression of p16 protein was also found. One another HPV positive case with PCR could not be typed with genotyping. Thus, the investigation of HPV genotyping is not useful in identifying dysplasic lesions using aged archived paraffin blocks or due to insufficient quantity (18) . There was a correlation between high grade dysplasia and Ki67, p16, EBV expression and apoptosis .
CONCLUSIONS
This study did not reveal a statistically significant relationship between HPV and EBV and neoplastic changes. It appears that HPV and EBV do not play major role in TSD, although HPV involvement cannot completely be ruled out in lesions of the tongue.
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